Anatara Lifesciences Ltd has released a press release.
Funding Advance on R&D Refund
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Phase II GaRP-IBS Trial Headline Analysis of Results
- Phase II GaRP-IBS Trial & Anti-Obesity Project Updates
- Appendix 4D & Half Year Report 31 December 2024
- Australian Patent Granted for GaRP Product
- GaRP-IBS Clinical Trial Update
Later from Anatara Lifesciences
- Phase II GaRP-IBS Trial Internal Analyses of Data Subsets
- Hong Kong Patent Granted for GaRP
- Anatara receives $969,455 in R&D Tax Incentive for FY25
- Appendix 4E & Financial Report 30 June 2025
- Pause in Trading
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences